Cargando…

BRAF mutations may identify a clinically distinct subset of glioblastoma

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. Prior studies examining the mutational landscape of GBM revealed recurrent alterations in genes that regulate the same growth control pathways. To this regard, ~ 40% of GBM harbor EGFR alterations, whereas BRAF variants a...

Descripción completa

Detalles Bibliográficos
Autores principales:	McNulty, Samantha N., Schwetye, Katherine E., Ferguson, Cole, Storer, Chad E., Ansstas, George, Kim, Albert H., Gutmann, David H., Rubin, Joshua B., Head, Richard D., Dahiya, Sonika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501013/ https://www.ncbi.nlm.nih.gov/pubmed/34625582 http://dx.doi.org/10.1038/s41598-021-99278-w

Ejemplares similares

Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma
por: Dahiya, Sonika, et al.
Publicado: (2012)

BRAF Alteration in Central and Peripheral Nervous System Tumors
por: Srinivasa, Komal, et al.
Publicado: (2020)

Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma
por: Khaddour, Karam, et al.
Publicado: (2021)

KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth
por: Anastasaki, Corina, et al.
Publicado: (2017)

Characterising Distinct Migratory Profiles of Infiltrating T-Cell Subsets in Human Glioblastoma
por: Kollis, Paris M., et al.
Publicado: (2022)

ABCG1 maintains high-grade glioma survival in vitro and in vivo
por: Chen, Yi-Hsien, et al.
Publicado: (2016)

LGG-07. IS BRAF ALTERATION OR A HISTOLOGIC ‘QUALIFIER’ A PREDICTOR OF OUTCOME IN PEDIATRIC PILOCYTIC ASTROCYTOMA?
por: Cler, Samuel J, et al.
Publicado: (2021)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
por: Khaddour, Karam, et al.
Publicado: (2021)

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2020)

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2023)

Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
por: Bayik, Defne, et al.
Publicado: (2022)

Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
por: Hirbe, Angela C., et al.
Publicado: (2016)

Midkine activation of CD8(+) T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth
por: Guo, Xiaofan, et al.
Publicado: (2020)

Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study
por: Naguib, Adam, et al.
Publicado: (2010)

The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
por: Khaddour, Karam, et al.
Publicado: (2020)

Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
por: Li, Kay Ka-Wai, et al.
Publicado: (2019)

Diffusion histology imaging differentiates distinct pediatric brain tumor histology
por: Ye, Zezhong, et al.
Publicado: (2021)

Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
por: Khaddour, Karam, et al.
Publicado: (2021)

Characterization of lymphocyte subsets over a 24-hour period in Pineal-Associated Lymphoid Tissue (PALT) in the chicken
por: Mosenson, Jeffrey A, et al.
Publicado: (2006)

BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?
por: Bouchè, Victoria, et al.
Publicado: (2021)

Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
por: Ansstas, George, et al.
Publicado: (2016)

Spitz Melanoma is a Distinct Subset of Spitzoid Melanoma
por: Raghavan, Shyam, et al.
Publicado: (2020)

BRAF V600E mutation and BRAF VE1 immunoexpression profiles in different types of glioblastoma
por: Tosuner, Zeynep, et al.
Publicado: (2018)

Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2023)

Immune cell analysis of pilocytic astrocytomas reveals sexually dimorphic brain region-specific differences in T-cell content
por: Chen, Jie, et al.
Publicado: (2021)

Differential MHC class I expression in distinct leukocyte subsets
por: Greene, Justin M, et al.
Publicado: (2011)

Identification of distinct polarized macrophage subsets in inflammatory arthritis
por: Ambarus, C, et al.
Publicado: (2010)

Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation
por: de Andrade Costa, Amanda, et al.
Publicado: (2021)

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation
por: Caliò, Anna, et al.
Publicado: (2016)

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
por: Ma, Sirui, et al.
Publicado: (2020)

Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation
por: Fan, Xiaoqing, et al.
Publicado: (2021)

Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis
por: Mizoguchi, Fumitaka, et al.
Publicado: (2018)

Adult classical glioblastoma with a BRAF V600E mutation
por: Takahashi, Yoshinobu, et al.
Publicado: (2015)

Distinct T cell subsets in adipose tissue are associated with obesity
por: Haugstøyl, Martha E., et al.
Publicado: (2022)

Functionally distinct NKT cell subsets and subtypes
por: Seino, Ken-ichiro, et al.
Publicado: (2005)

Regulation of the Migration of Distinct Dendritic Cell Subsets
por: Feng, Meng, et al.
Publicado: (2021)

Pituitary Adenoma in Pediatric and Adolescent Populations
por: Chen, Jie, et al.
Publicado: (2019)

Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers
por: Gopal, Priyanka, et al.
Publicado: (2019)

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
por: Robinson, Giles W, et al.
Publicado: (2014)

Distinct T cell signatures define subsets of patients with multiple sclerosis
por: Johnson, Mark C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9qebeoanictvbk9dgp7l2f6aot